By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

Key Highlights of Chemistry today

Today’s Political Science Science Briefing | March 28th 2026, 1:00:14 pm

Today’s Neurology Science Briefing | March 28th 2026, 1:00:14 pm

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Pathology - A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Pathology

A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Last updated: February 4, 2026 9:17 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

A 3D blueprint for ovarian cancer: Decellularised tissue models therapy response

Researchers have developed a novel three-dimensional model of high-grade serous ovarian cancer (HGSOC) metastasis using a decellularised peritoneal matrix. This advanced in vitro platform aims to more accurately replicate the complex tumor microenvironment of peritoneal carcinomatosis, a common and challenging pattern of spread. The model provides a valuable tool for investigating disease progression and, critically, for studying the response of metastatic cells to various therapeutic agents, bridging a gap between traditional cell cultures and in vivo studies.

Why it might matter to you: For pathologists focused on tumor biology and diagnostics, this model represents a significant step in translational research. It offers a sophisticated system to pre-clinically test how specific genetic mutations and biomarkers influence treatment efficacy in a realistic tissue context. This could directly inform the development of more targeted molecular diagnostics and help correlate histopathological findings from biopsies with predicted therapeutic outcomes, enhancing personalized treatment strategies.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article A New Frontier in Neuropathic Pain: Targeting TNF in ALS Mice
Next Article The global diagnostic gap in cystic fibrosis revealed by genomic data
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

The Diagnostic Dilemma of Missing Variants in Alport Syndrome

Metabolic Competition in the Tumor Microenvironment: A New Frontier for Diagnostic Biomarkers

STING in Kidney Disease: A Modulator, Not a Master Switch

Liver Metabolomics: Deciphering the Molecular Shift from Steatosis to Steatohepatitis

Navigating the Diagnostic Gray Zone in Preimplantation Genetic Testing

A Molecular Blueprint for Microglial Dysfunction in a Rare Bone Disorder

PET/CT and Molecular Profiling: A New Blueprint for Managing Advanced Lung Cancer

The Prognostic Power of Dual-Positive Circulating Tumor Cells in Metastatic Breast Cancer

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Gastroenterology
  • Social Sciences
  • Surgery
  • Natural Language Processing
  • Cell Biology
  • Engineering
  • Genetics
  • Immunology

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?